NPPA Slapped Rs 9,950 Cr Penalty On Pharma Firms, Recovered Only 14.25%
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has initiated action in 2,605 cases of drug overpricing from 31st March 1979 to 31st March 2025, involving an overcharged amount, along with interest and penalty, totaling Rs 9,950.10 crore. Of this, the government has so far recovered Rs 1,418.80 crore (ie. 14.25 percent) from the pharmaceutical companies concerned, informed the Minister of State for Chemicals and Fertilizers, Anupriya Patel, in a written reply during the recent Lok Sabha session.
Responding to a question raised by MPs Azad Kirti Jha, Chandra Prakash Choudhary, and Sanatan Pandey, Patel stated that the NPPA monitors medicine prices on an ongoing basis and acts wherever overcharging is found.
“The National Pharmaceutical Pricing Authority (NPPA) monitors the prices of medicines on an ongoing basis and wherever pharmaceutical companies are found to be overcharging the consumer in sale of medicine, it initiates action against such companies in accordance with the provisions of the Drugs (Prices Control) Order, 2013,” she said.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.